Johnson & Johnson’s earnings have come in, and they’re mixed. They’ve missed projections in two out of three of their business units but were over in their bottom line.
J&J Earnings: $502 Million From Vaccine Sales
By Fae Courter
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.